Related Experiment Video
Updated: Oct 1, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Differences between COVID-19-induced acute kidney injury and chronic kidney disease patients
Gustavo Aroca-Martínez1,2, Carlos G Musso1,3,4, Lil Avendaño-Echavez1
1Universidad Simón Bolívar, Faculdade de Ciências da Saúde, Barranquilla, Colômbia.
Insights
COVID-19 significantly impacts kidney function, causing acute kidney injury (AKI) in 33% of patients. This study highlights distinct clinical patterns and outcomes for patients with normal renal function versus those with chronic kidney disease.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 is associated with acute kidney injury (AKI-COVID19).
- This study compares AKI in patients with normal renal function (AKI-NRF) versus chronic kidney disease (AKI-CKD).
Purpose of the Study:
- To delineate the distinct clinical presentations and outcomes of AKI-COVID19 in patients with and without pre-existing chronic kidney disease.
- To identify key differences in patient characteristics and disease progression between AKI-NRF and AKI-CKD cohorts.
Main Methods:
- Retrospective analysis of 572 COVID-19 patients, with a focus on 188 who developed AKI.
- Collection of epidemiological data, serum parameters, and clinical frailty status.
- Statistical comparison between AKI-NRF, AKI-CKD, and non-AKI patient groups.
Main Results:
- AKI incidence was 33%, with 16% requiring renal replacement therapy and an overall mortality of 68%.
- AKI-CKD patients exhibited higher rates of hypertension, cardiac disease, elevated C-reactive protein, and lower albumin.
- AKI-NRF patients showed significantly higher mortality, invasive ventilation needs, and D-dimer levels.
Conclusions:
- Distinct clinical profiles exist between AKI-NRF and AKI-CKD patients.
- Understanding these differences is crucial for targeted management strategies in AKI-COVID19.
Introduction:
This article describes the main differences between COVID-19-induced acute kidney injury (AKI-COVID19) in patients with previous normal renal function (AKI-NRF) and those with chronic kidney disease (AKI-CKD) treated in a high complexity clinic in Barranquilla (Colombia).
Material And Methods:
The patients included in this study (n: 572) were those with a positive diagnosis of COVID-19 confirmed by detection of a positive PCR for SARS-CoV-2. Of these patients, 188 developed AKI during their hospital stay. Patients' epidemiological data, serum parameters, and clinical frailty status were recorded. Statistical analysis and comparison among AKI-NRF, AKI-CKD, and non-AKI patients were performed.
Results:
The incidence of COVID-19-induced AKI was 33%, with the majority classified as AKIN 1, 16% requiring renal replacement therapy, and AKI-COVID19 mortality of 68%. A significantly higher prevalence of hypertension, cardiac disease, and serum reactive C-protein and lower albumin values in AKI-CKD patients was recorded. Mortality rate, invasive ventilation requirement, and D-dimer levels were significantly higher in AKI-NRF patients.
Conclusion:
Different clinical patterns between AKI-NRF and AKI-CKD were documented.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care

